RecruitingNCT06190626

Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder

Studying Zellweger syndrome

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Principal Investigator: Nancy E Braverman, MD, MS
McGill University Health Centre/Research Institute of the McGill University Health Centre
Enrollment: 30 enrolled
Eligibility: All sexes
Timeline: 2023 – 2029

Study locations (3)

University of Rochester Medical Center/Flaum Eye Institute, Rochester, New York, United States
Eye Institute of Alberta, Edmonton, Alberta, Canada
Research Institute-McGill University Health Center, Montreal, Quebec, Canada

Collaborators

Canadian Institutes of Health Research (CIHR)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06190626 on ClinicalTrials.gov

← Back to all trials